ArticleBMC biology2025
A robust deep learning framework for RNA 5-methyluridine modification prediction using integrated features.
Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- DeepFusion-ACSM: an interpretable hybrid ML-DL ensemble model for anticancer small-molecule activity prediction.Journal of computer-aided molecular design · 2026Article
- ESM2-Kcr: a novel model combining protein language model and deep learning methods for predicting lysine crotonylation sites.Journal of computer-aided molecular design · 2026Article
- MBPBERT: A Large Language Model for Metal-Binding Peptide Discovery.Interdisciplinary sciences, computational life sciences · 2026Article
- Peptide language pragmatic analysis and two-stage hierarchical learning framework for therapeutic peptide prediction.BMC biology · 2026Article
- Deep learning based individualized cross-platform molecular subtype classification of B-lineage acute lymphoblastic leukemia.NPJ precision oncology · 2026Article
- Development and validation of an early risk prediction model based on inflammatory and metabolically derived markers for early diagnosis of diabetic kidney disease.Scientific reports · 2026Article
- Chronic liver disease classification using deep learning with SHAP-optimized hybrid features.iScience · 2025Article
- Deep recurrent models for forecasting infectious diseases.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe discovery of RNA 5-methyluridine (m5U) modifications is vital in computational biology due to their essential significance in different biological processes. This study presents a powerful predictor named 5-meth-Uri, which improves the overall accuracy of m5U modification predictions. The proposed method combines a composite of dinucleotide and trinucleotide-based auto-cross covariance with six physicochemical parameters to generate a feature vector. We select essential features using an unsupervised Principal Component Analysis (PCA) technique to enhance the model's efficiency. Finally, an intelligent computation Deep Neural Network (DNN) was utilized to classify RNA 5-methyluridine (m5U).
resultsThe model's performance was evaluated on two benchmark datasets, namely mature mRNA and full transcript, using tenfold cross-validation and an independent test. The proposed model achieved an average accuracy of 95.13% and 97.36% on the training set and 95.73% and 96.51% on the independent test sets for the full transcript and mature mRNA datasets, respectively. 5-meth-Uri demonstrated around 7.15% and 3.98% higher accuracy on training data and 5.42% and 3.52% higher accuracy on independent samples for both datasets compared to existing models.
conclusionsIts high accuracy and reliability make 5-meth-Uri a promising tool for researchers with potential biomedical and pharmaceutical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.